- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03585985
Investigation of a Link Between Heart Rate Variability and Frailty in Geriatric Patients
Investigation of a Link Between Heart Rate Variability and Frailty in Geriatric Patients Before and After Rehabilitation With Simultaneous Evaluation of a New Camera-based Technology for Measurement of Vital Signs
Study Overview
Status
Conditions
Detailed Description
Frailty is an important geriatric syndrome, which indicates a reduced maximum resilience of patients and their organ system against external stressors. According to Fried's classification, frailty comprises of unintentional weight loss, exhaustion, muscle weakness, slowness while walking and low levels of activity. In geriatric patients, frailty is associated with a higher mortality and morbidity. Moreover, frailty patients are more often dependent on assistance after hospitalisation than non-frailty patients.
During geriatric therapy, geriatric patients are treated with multimodal rehabilitation comprising of activating nursing, physiotherapy, occupational therapy, psychiatric and speech therapy in order to increase mobility and patients' ability to help themselves. Success of rehabilitation measures is measured using the geriatric assessment (e.g. Barthel Index, Timed up and go test, Mini-Mental State Examination, Geriatric Depression Scale, measurement of hand power) at the beginning and end of the therapy. This geriatric therapy including the named geriatric assessment is not study-specific and is not prescribed by a study protocol, but is a routine treatment for frail patients.
Apart from these routinely used tests, recent literature indicated that heart rate variability, which can be easily measured with an ECG, could be an indicator for frailty. Beyond the medical problem whether heart rate variability can be used as a surrogate parameter for frailty, this study also has a technical aspect. In biomedical engineering, non-contact monitoring of vital signs has been an important and promising development in the last decade. Therefore, this study will also investigate if camera-based technologies such as photoplethysmography imaging (PPGI) and infrared thermography (IRT) can be used in a clinical environment for non-contact measurement of vital signs (heart rate, heart rate variability, respiratory rate) in geriatric patients. In this study, monitoring (with conventional and contactless technologies) should not trigger any observable/examining effect, but is merely a means to the end of observing the already existing HRV (and other vital parameters).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
North Rhine-Westphalia
-
Aachen, North Rhine-Westphalia, Germany, 52074
- Department of Geriatrics, University Hospital RWTH Aachen Aachen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Group 1: aged above 70 if they have typical geriatric multimorbidity, otherwise aged above 80, patient on the geriatric ward in the hospital "Franziskhospital Aachen"
- Group 2 (Healthy volunteers): aged above 70, healthy and in good physical condition
- Written informed consent by patient / volunteer
Exclusion Criteria:
- Inability to consent
- Pace maker
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1
10 patients aged above 70 years with typical geriatric multimorbidity or aged above 80 years otherwise, patient in the hospital Franziskushospital Aachen on the ward of geriatric medicine
|
Measurement of reference data: heart rate, heart rate variability and respiratory rate
Camera-based technology for the determination of heart rate variability (PPGI) and contactless measurement of breathing rate (IRT)
|
|
Group 2
10 healthy elderly people above 70 years, healthy
|
Measurement of reference data: heart rate, heart rate variability and respiratory rate
Camera-based technology for the determination of heart rate variability (PPGI) and contactless measurement of breathing rate (IRT)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Link between heart rate variability and frailty
Time Frame: approx. 14 days (duration of geriatric complex therapy)
|
heart rate variability is measured by ECG; frailty is evaluated by geriatric assessment (questionnaires) both investigations are not related to the study but geriatric complex therapy |
approx. 14 days (duration of geriatric complex therapy)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation and precision of camera-based heart rate measurement with reference data from standard patient monitor
Time Frame: approx. 14 days (duration of geriatric complex therapy)
|
the following devices / methods are used to record the heart rate:
|
approx. 14 days (duration of geriatric complex therapy)
|
|
Correlation and precision of camera-based heart rate variability with reference data from standard patient monitor
Time Frame: approx. 14 days (duration of geriatric complex therapy)
|
the following devices are used to record the heart rate variability:
|
approx. 14 days (duration of geriatric complex therapy)
|
|
Correlation and precision of camera-based respiratory rate with reference data from standard patient monitor
Time Frame: approx. 14 days (duration of geriatric complex therapy)
|
the following devices / methods are used to record the respiratory rate:
|
approx. 14 days (duration of geriatric complex therapy)
|
|
Development of Frailty / geriatric assessment at the beginning and end of the geriatric early-rehabilitation complex-therapy
Time Frame: approx. 14 days (duration of geriatric complex therapy)
|
Frailty is evaluated by geriatric assessment (questionnaires)
|
approx. 14 days (duration of geriatric complex therapy)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cornelius Bollheimer, Univ.-Prof. Dr. med., Department of Geriatrics, University Hospital RWTH Aachen Aachen, NRW, Germany, 52074 Contacts:
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-059
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fragility
-
University Hospital, ToulouseWithdrawn
-
Cardenal Herrera UniversityCompleted
-
Institut National de la Santé Et de la Recherche...Completed
-
Centre Hospitalier Universitaire de NiceCompleted
-
Texas Woman's UniversityRetirement Research FoundationCompletedFragilityUnited States
-
Hospital Pengajar Universiti Putra MalaysiaNot yet recruitingFragility FractureMalaysia
-
National Yang Ming UniversityCompleted
-
Hanze UniversityUniversity Medical Center GroningenUnknownPhysical Disability | FragilityNetherlands
-
Elena Pérez Expósito, MDNot yet recruiting
-
Laval UniversityRecruitingEvaluation of Gas Humidification Practices in Patients Under Invasive Mechanical Ventilation (FP950)Respiratory Complication | Humidifier Lung | Mechanical FragilityCanada
Clinical Trials on Standard patient monitor
-
M.D. Anderson Cancer CenterActive, not recruitingMetastatic Pancreatic Carcinoma | Stage IV Pancreatic Cancer AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Stage IV Colon Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8 | Stage IVA Colon Cancer AJCC v8 | Stage IVA Rectal Cancer AJCC v8 | Stage IVB Colon Cancer AJCC v8 | Stage IVB Rectal Cancer... and other conditionsUnited States
-
William Marsh Rice UniversityKamuzu University of Health SciencesRecruiting
-
Medtronic Cardiac Rhythm and Heart FailureTerminatedHeart Diseases | Chagas DiseaseColombia, Argentina
-
Noninvasive Medical Technologies, Inc.University of Florida; Shand's Medical CenterCompletedHeart Failure | Hypertension | Trauma | Dyspnea | Pacemaker
-
Dhanunjaya Lakkireddy, MD, FACCWithdrawnAtrial FibrillationUnited States
-
Philips Clinical & Medical Affairs GlobalRecruiting
-
Philips Clinical & Medical Affairs GlobalRecruiting
-
Stanford UniversityCompletedType 2 DiabetesUnited States
-
Spire, Inc.The University of Texas Health Science Center at San Antonio; Pulmonary Associates...CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Philips HealthcareCompletedSepsis | Renal Failure | Pulmonary Edema | Cardio-pulmonary ArrestAustralia